Article

Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.

Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201, USA.
Acta Neuropathologica (Impact Factor: 9.73). 01/2012; 123(1):105-17. DOI: 10.1007/s00401-011-0893-0
Source: PubMed

ABSTRACT In sporadic Alzheimer's disease (AD), neurofibrillary lesion formation is preceded by extensive post-translational modification of the microtubule associated protein tau. To identify the modification signature associated with tau lesion formation at single amino acid resolution, immunopurified paired helical filaments were isolated from AD brain and subjected to nanoflow liquid chromatography-tandem mass spectrometry analysis. The resulting spectra identified monomethylation of lysine residues as a new tau modification. The methyl-lysine was distributed among seven residues located in the projection and microtubule binding repeat regions of tau protein, with one site, K254, being a substrate for a competing lysine modification, ubiquitylation. To characterize methyl lysine content in intact tissue, hippocampal sections prepared from post mortem late-stage AD cases were subjected to double-label confocal fluorescence microscopy using anti-tau and anti-methyl lysine antibodies. Anti-methyl lysine immunoreactivity colocalized with 78 ± 13% of neurofibrillary tangles in these specimens. Together these data provide the first evidence that tau in neurofibrillary lesions is post-translationally modified by lysine methylation.

0 Bookmarks
 · 
155 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Convincing epidemiological data suggest an inverse association between cancer and neurodegeneration, including Alzheimer's disease (AD). Since both AD and cancer are characterized by abnormal, but opposing cellular behavior, i.e., increased cell death in AD while excessive cell growth occurs in cancer, this motivates us to initiate the study into unraveling the shared genes and cell signaling pathways linking AD and glioblastoma multiform (GBM). In this study, a comprehensive bioinformatics analysis on clinical microarray datasets of 1,091 GBM and 524 AD cohorts was performed. Significant genes and pathways were identified from the bioinformatics analyses - in particular ERK/MAPK signaling, up-regulated in GBM and Angiopoietin Signaling pathway, reciprocally up-regulated in AD - connecting GBM and AD (P < 0.001), were investigated in details for their roles in GBM growth in an AD environment. Our results showed that suppression of GBM growth in an AD background was mediated by the ERK-AKT-p21-cell cycle pathway and anti-angiogenesis pathway.
    Scientific Reports 01/2013; 3:3467. · 5.08 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The accumulation of hyperphosphorylated tau is a common feature of several dementias. Tau is one of the brain microtubule-associated proteins. Here we discuss tau's functions in microtubule assembly and stabilization and with regard to its interactions with other proteins. We describe and analyze important post-translational modifications: hyperphosphorylation, ubiquitination, glycation, glycosylation, nitration, polyamination, proteolysis, acetylation, and methylation. We discuss how these post-translational modifications can alter tau's biological function. We analyze the role of mitochondrial health in neurodegeneration. We propose that microtubules could be a therapeutic target and review different approaches. Finally, we consider whether tau accumulation or its conformational change is related to tau-induced neurodegeneration, and propose a mechanism of neurodegeneration.
    Neuroscience Bulletin 04/2014; 30(2):346-58. · 1.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dementia pugilistica (DP) is a suite of neuropathological and cognitive function declines following chronic traumatic brain injury (TBI) present in approximately 20% of retired boxers. Epidemiological studies indicate TBI is a risk factor for neurodegenerative disorders including Alzheimer's disease (AD) and Parkinson's disease (PD). Some biochemical alterations observed in AD and PD may be recapitulated in DP and other TBI subjects. In this report we investigate long-term biochemical changes in the brains of former boxers with neuropathogically confirmed DP. Our experiments revealed biochemical and cellular alterations in DP that are complementary to and extend information already provided by histological methods. ELISA and 1D- and 2D-Western blot techniques revealed differential expression of select molecules between 3 DP cases and 3 age-matched non-demented control (NDC) cases without a history of TBI. Structural changes such as disturbances in the expression and processing of glial fibrillary acidic protein, tau and α-synuclein were evident. The levels of the Aβ-degrading enzyme neprilysin were reduced in the DP cases. Amyloid-β levels were elevated in the DP subject with the concomitant diagnosis of AD. In addition, the levels of brain-derived neurotrophic factor and the axonal transport proteins kinesin and dynein were substantially decreased in DP relative to NDC subjects. Traumatic brain injury is a risk factor for dementia development and our findings are consistent with permanent structural and functional damage in the cerebral cortex and white matter of boxers. Understanding the precise threshold of damage required for the induction of pathology in DP and TBI is vital.
    Journal of neurotrauma 12/2012; · 4.25 Impact Factor

Full-text (2 Sources)

View
39 Downloads
Available from
May 30, 2014